Nchi: Israeli
Lugha: Kiingereza
Chanzo: Ministry of Health
SALMETEROL AS XINAFOATE
GLAXO SMITH KLINE (ISRAEL) LTD
R03AC12
POWDER FOR INHALATION
SALMETEROL AS XINAFOATE 50 MCG
INHALATION
Required
GLAXO WELLCOME PRODUCTION, FRANCE
SALMETEROL
SALMETEROL
Salmeterol is a selective beta-2-agonist indicated for reversible airways obstruction in patients with asthma and chronic obstructive pulmonary disease (COPD).In asthma (including nocturnal asthma and exercise induced symptoms) it is indicated for those treated with inhaled corticosteroids who require a long-acting beta agonist in accordance with current treatment guidelines.
2020-03-31
[לוגו מדינת ישראל] [http://www.gov.il/] [http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד הבריאות] [*5400] [http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx] [http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx] הציבור הרחב עסקים ומוסדות עובדים בבריאות חפש מידע תפריט * [סגירה] סגור * דף הבית [http://www.health.gov.il/] * אודות * אודות המשרד [http://www.health.gov.il/About/Pages/about_us.aspx] * תוכנית עבודה [http://www.health.gov.il/About/Pages/Agenda.aspx] * תקציב המשרד [http://www.health.gov.il/About/Pages/budget.aspx] * תרשים מבנה ארגוני [http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx] * בעלי תפקידים [http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx] * יחידות המשרד [http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx] * לשכות הבריאות [http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3] * אמנת שירות [http://www.health.gov.il/About/sla/Pages/default.aspx] * אותות ופרסים [http://www.health.gov.il/About/Awards/Pages/mifal.aspx] * פרוייקטים תשתיתיים [http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx] * דרושים [http://www.health.gov.il/About/Careers/Pages/default.aspx] * מנכ"לי משרד הבריאות לדורותיהם [http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx] * יחידות המשרד * יחידות המשרד [http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx] * לשכות הבריאות [http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx] * וועדות ומועצות [http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx] * נושאים * בריאות הנפש [http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx] * בריאות הסביבה [http://www.health.gov.il/Subjects/Environmental_Health/ Soma hati kamili
_Page 1 of 11 _ SEREVENT DISKUS 1. NAME OF THE MEDICINAL PRODUCT Serevent Diskus 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Serevent Diskus is a moulded plastic device containing a foil strip with regularly spaced blisters each containing 50 micrograms of salmeterol (as xinafoate). For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Inhalation powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Salmeterol is a selective β 2 -agonist indicated for reversible airways obstruction in patients with asthma and chronic obstructive pulmonary disease (COPD). In asthma (including nocturnal asthma and exercise induced symptoms) it is indicated for those treated with inhaled corticosteroids who require a long-acting beta agonist in accordance with current treatment guidelines. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Serevent Diskus is not a replacement for inhaled or oral corticosteroids which should be continued at the same dose, and not stopped or reduced, when treatment with Serevent Diskus is initiated. Serevent Diskus is for inhalation use only. Serevent Diskus should be used regularly. The full benefits of treatment will be apparent after several doses of the drug. In asthma _Adults (including the elderly):_ One inhalation (50 micrograms) twice daily, increasing to two inhalations (2 x 50 micrograms) twice daily if required. _Children 4 years and over:_ One inhalation (50 micrograms) twice daily. The dosage or frequency of administration should only be increased on medical advice. _Page 2 of 11 _ There are insufficient clinical data to recommend the use of Serevent Diskus in children under the age of four. In chronic obstructive pulmonary disease _Adults (including the elderly):_ One inhalation (50 micrograms) twice daily. _Children:_ Not appropriate. _Special patient groups:_ There is no need to adjust the dose in patients with impaired renal function. Using the Diskus: The Diskus should be used in a standing or sitting position. The device is opened and primed by sliding the lever. The Soma hati kamili